An official website of the United States government

This repository is under review for potential modification in compliance with Administration directives.
NIH: National Institute of Diabetes and Digestive and Kidney Diseases
NIDDK Central Repository
Search
Filters

Study Acronym

NAFLD Pediatric

1 - 10 of 10 Results
  • 1
Page
Show:
Study Search Results Table
Title
PMID
PMCID
Public Release Type
Publication Year
DOI
Study Acronym
Study Network
Request ID(s)
Public Release Origin
Association Between Polypharmacy, Patient Reported Symptoms, and Quality of Life among Nonalcoholic Fatty Liver Disease Patients in the United States.Journal202210.1007/s40267-022-00957-zNAFLD Adult, PIVENS, NAFLD Pediatric, TONICNonalcoholic Steatohepatitis Clinical Research Network (NASH)23211Secondary Research
Defining the serum proteomic signature of hepatic steatosis, inflammation, ballooning and fibrosis in non-alcoholic fatty liver disease.36528237PMC10165617Journal202310.1016/j.jhep.2022.11.029NAFLD PediatricNonalcoholic Steatohepatitis Clinical Research Network (NASH)22511, 23382Secondary Research
Effect of Polypharmacy on Health-related Quality of Life in Pediatric Patients with Nonalcoholic Fatty Liver Disease in the United States.Journal2024NAFLD Adult, TONIC, PIVENS, NAFLD PediatricNonalcoholic Steatohepatitis Clinical Research Network (NASH)23211Secondary Research
Low Testosterone Is Associated With Nonalcoholic Steatohepatitis and Fibrosis Severity in Men.31812658PMC7272262Journal202110.1016/j.cgh.2019.11.053NAFLD PediatricNonalcoholic Steatohepatitis Clinical Research Network (NASH)22511Secondary Research
Metabolome × Microbiome Changes Associated with a Diet-Induced Reduction in Hepatic Fat among Adolescent Boys.36984841PMC10053986Journal202310.3390/metabo13030401NAFLD PediatricNonalcoholic Steatohepatitis Clinical Research Network (NASH)22449Secondary Research
Microbiome Signatures Associated With Steatohepatitis and Moderate to Severe Fibrosis in Children With Nonalcoholic Fatty Liver Disease.31255652PMC6756995Journal201910.1053/j.gastro.2019.06.028NAFLD PediatricNonalcoholic Steatohepatitis Clinical Research Network (NASH)22511Secondary Research
Nonalcoholic fatty liver disease risk and histologic severity are associated with genetic polymorphisms in children.35560106PMC9653518Journal202310.1002/hep.32570NAFLD PediatricNonalcoholic Steatohepatitis Clinical Research Network (NASH)22511, 23382Secondary Research
Randomized placebo-controlled trial of losartan for pediatric NAFLD.35133671PMC9288975Journal202210.1002/hep.32403NAFLD PediatricNonalcoholic Steatohepatitis Clinical Research Network (NASH)22449Secondary Research
The Effect of Polypharmacy on Quality of Life in Adult Patients with Nonalcoholic Fatty Liver Disease in the United States.35064417Journal202210.1007/s11136-022-03090-6TONIC, NAFLD Pediatric, PIVENS, NAFLD AdultNonalcoholic Steatohepatitis Clinical Research Network (NASH)23211Secondary Research
The roles of type 2 diabetes and obesity in disease activity and progression of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis37933187Journal202410.1080/03007995.2023.2279676FLINT, CyNCh, NAFLD Adult, NAFLD Pediatric, PIVENS, TONICNonalcoholic Steatohepatitis Clinical Research Network (NASH)23059Secondary Research
  • 1
Page